1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > Drug Eluting Stent Market in China - Industry Research Report 2015-2019

Drug Eluting Stent Market in China - Industry Research Report 2015-2019

  • October 2015
  • -
  • Infiniti Research Limited
  • -
  • 56 pages

About drug eluting stent
Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).

Technavio's analysts forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.

Covered in this report
This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.
Technavio's report, Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Vendors
- Abbott Vascular
- Lepu Medical
- Medtronic
- MicroPort Scientific
- Shandong JW Medical Systems
Other prominent vendors
- Biosensors International
- Boston Scientific
- Cook Medical
- Opto Circuit
- QualiMed
- Sinomed
- Terumo Medical

Market driver
- High prevalence of CVDs
- For a full, detailed list, view our report

Market challenge
- Availability of alternative coronary stents
- For a full, detailed list, view our report

Market trend
- Increase in demand for minimally-invasive procedures
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Drug Eluting Stent Market in China - Industry Research Report 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Stents: An overview
Stents
PART 06: Market landscape
Market overview
Five force analysis
PART 07: Healthcare reform in China
PART 08: Opportunities for global and local vendors
Local vendors
Global vendors
PART 09: Market drivers
High prevalence of CVDs
Advances in technology
Favorable reimbursement policies
Low risk of contracting restenosis
PART 10: Impact of drivers
PART 11: Market challenges
Availability of alternative coronary stents
Limitations of drug-eluting stents
Stringent regulations for device approval
Preference for drugs over stents
PART 12: Impact of drivers and challenges
PART 13: Market trends
Increased demand for minimally invasive procedures
Government support for local manufacturers
Growing popularity of hybrid procedures
Popularity of medical tourism
PART 14: Vendor landscape
Competitive scenario
Major vendor analysis 2014
Other prominent vendors
PART 15: Key vendor analysis
MicroPort
Lepu Medical Technology
JW Medical Systems
Abbott Vascular
Medtronic
Business overview
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Cross-sectional view of a stent with drug-loaded polymeric coating
Exhibit 03: Some agents used in drug eluting stents
Exhibit 04: Brief history of stents
Exhibit 05: Drug eluting stent market in China 2014-2019 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Disease mortality in China 2014
Exhibit 08: Healthcare reforms in China
Exhibit 09: Number of medical institutes in China until 2012
Exhibit 10: Impact of drivers
Exhibit 11: Impact of drivers and challenges
Exhibit 12: Market share analysis of vendors
Exhibit 13: Microport Medical: Key takeaways
Exhibit 14: Lepu Medical: Key takeaways
Exhibit 15: Shandong JW Medical System: Key takeaways
Exhibit 16: Abbott Vascular: Key takeaways
Exhibit 17: Medtronic: Key takeaways
Exhibit 18: Microport: Business segmentation 2014 by revenue
Exhibit 19: MicroPort: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 20: Lepu Medical Technology: Product segmentation
Exhibit 21: Lepu Medical Technology: Revenue breakup 2014
Exhibit 22: JW Medical Systems: Product portfolio
Exhibit 23: Abbott Vascular: Product categories

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Biodegradable Stents Market: Overview Biodegradable Stents are the third generation of stents used in the treatment of coronary artery diseases, which are completely absorbed in the body after the ...

Coronary Stent Market by Type, Mode of Delivery, Material, Polymer, Copolymer, & End User - Global Forecasts to 2021

Coronary Stent Market by Type, Mode of Delivery, Material, Polymer, Copolymer, & End User - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021 Major factors contributing to the growth of the global ...

Interventional Cardiology & Peripheral Vascular Devices Market by Type - Forecasts to 2021

Interventional Cardiology & Peripheral Vascular Devices Market by Type - Forecasts to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1%. On the basis of product, this market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.